Holly graduated from the University of Cambridge with a degree in Natural Sciences. For her thesis, she investigated the within-host diversity of influenza infections using statistical methods. In 2016, she undertook an internship at the Francis Crick Institute, London, during which she investigated potential new methods of influenza surveillance and vaccine research.
Holly joined the Huber group in September 2017 for a PhD, where her work focuses on using multi-omic data to understand drug responses in leukaemia patients. She is working jointly with the Dietrich group at the National Centre for Tumour Diseases, Heidelberg, performing experiments and gaining clinical insight to support her bioinformatic analysis.